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Abstract 
Purpose: The colorectal cancer (CRC) is the third leading cause of death in Korea. Ulcerative 
colitis (UC) is regarded as a risk factor of CRC. The aim of study is to confirm the incidence of 
CRC among subjects with and without a diagnosis of UC based on a sample of the Korean 
population. This study identified the effect of UC on incidence of CRC in Korea. 
Method: The data were from the population-based cohort containing National Health Insurance 
(NHI) claims from 2002 to 2013. We washed out first year (2002) for newly detected cases. 
Subjects who were under 20 years of age, diagnosed UC and CRC in 2002 development of CRC 
before diagnosis of UC since 2003, were excluded from analyses. Among 745,641 subjects during 
11 years of follow-up (2003-2013), 7,448 patients with CRC were newly detected. Cox 
proportional hazard regression model was used to estimate the hazard ratio (HR) of UC for CRC 
incidence. Confounding variables including gender, baseline age, type of social security, income 
level, residence, Charlson Comorbidity Index, hypertension and diabetes mellitus were 
incorporated into the model. 
Results: Overall annual incidence of UC and CRC were 6.7 and 95.4 per 100,000 during 11 years 
(2003~2013), respectively. Among 522 of newly detected UC cases, CRC incident cases were 12 
cases during 11 years. The effects were stronger for male. Advancing age and Charlson 
Comorbidity Index, hypertension and diabetes mellitus increased the risk of CRC. This study 
showed that the adjusted hazard ratio of UC in incidence of CRC is 1.92 (95% confidence interval: 
1.09-3.38). Also, male patients with UC have more HR than female patients with UC. 
Conclusion: The results of this study showed that patients with UC are the high risk group in 
incidence of CRC. Furthermore, the effects of UC in male patients are higher than those in female. 
The future study is needed to identify the effect of UC on mortality of CRC. 
Key words: Colorectal cancer, ulcerative colitis, Korea, population-based cohort study 
Introduction 
The crude incidence rate per 100,000 of colorectal 
cancer (CRC) of 2012 is 57.6 (male: 69.3; female 45.9) 
that is the third highest occurring cancer in Korea, and 
annual percentage change was 5.3% (male: 5.7%, 
female: 4.3%) during 14 years (1999 – 2012).[1] The 
crude death rate per 100,000 of CRC of 2012 was 16.2 
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(male: 18.5; female: 13.8) that is the fourth common 
cause of cancer death. 
The incidence of colorectal cancer has increased 
by 2 to 4 times during the past few decades in many 
Asian countries, including South Korea, China and 
Japan.[2] One of the reasons for increasing CRC is 
changes in dietary habits and lifestyle.[3, 4] Increased 
consumption of meat and animal fat might be a 
reason for rising incidence of colorectal cancer. 
The incidence rate of CRC was high in patients 
with long-term ulcerative colitis (UC).[5-7] The 
prevalence for UC was higher in Western countries 
than in Asian countries.[8-11] Even though the 
prevalence in Western countries has begun to 
stabilize, the prevalence of UC in Asia is steadily 
increasing even now.[9-11] Recent studies on UC 
effects on incidence of CRC are conducted in Eastern 
countries. Registration program for Rare Intractable 
Disease (RID), including UC, was established in 2006. 
According to registration program, annual incidence 
for UC was 4.6 per 100,000.[12] 
While the incidence of UC in Korea is still lower 
than those in Western countries, it is rapidly 
increasing.[13] It is anticipated that the incidence of 
UC-associated CRC will also increase. It is important 
to identify risk factors that influence developing CRC. 
The purpose of this study was to identify the 
association between UC and CRC using nationwide 
population-based cohort data in Korea. 
Method 
Data and Study Population 
National Health Insurance Service (NHIS) has 
established the nationwide cohort containing medical 
care claims from 2002, the baseline year. The number 
of cohort population was 1,025,340 accounting for 
about 2% of total Korean population. The cohort was 
followed until 2013. The sampling method is a 
stratified sampling by gender, age, and income level. 
Gender and age were categorized into 2 (male, 
female) and 18 (0, 1~79 (5yrs), 80+). Income level was 
categorized into 41 (medical aid: 1, industrial worker 
(IW): 20, self-employee (SE): 20). Total stratified 
categories were 1,476 strata. 
We washed out first year (2002) for newly 
detected cases. Subjects who were under 20 years of 
age (n=278,524), diagnosed UC (n=103) and CRC 
(n=1,029) in 2002, and development of CRC before 
diagnosis of UC since 2003 (n=64) were excluded from 
analyses (figure 1).  
Thus, the final sample included 745,641 subjects: 
366,251 male (49.1%), 379,390 female (50.9%). The data 
was observed for 7,807,280 person-years in subject. 
All components and procedures of this study were 
approved by the Institutional Review Board (IRB) of 
National Health Insurance Medical Center (NHIMC) 
(IRB File No.: NHIMC 2015-07-029). This study used 
National Sample Cohort data (NHIS-2016-2-026), 
provided by NHIS. 
 
 
Figure 1. Flowchart of the subjects included for analysis 
 
Study Variables 
The diagnosis of CRC was a dependent variable. 
The CRC consists of malignant neoplasm of colon 
(C18), malignant neoplasm of rectosigmoid junction 
(C19) and malignant neoplasm of rectum (C20). CRC 
is a disease originating from the epithelial cells lining 
the colon or rectum of the gastrointestinal tract. 
The diagnosis of UC was an independent 
variable. According to the 10th version of 
International Classification of Diseases (ICD-10), UC 
was designated with the code of main sick K51. The 
annual incidence of UC was 4.6 per 100,000 during 7 
years (2006-2012).[12] On average, patients with UC 
have used clinics or hospitals 6.4 times per year in 
Korea. Based on annual incidence and utilization, the 
patients with UC were defined as visiting clinics or 
hospitals ≥ 4 times annually. 
Confounding variables included gender, 
baseline age, type of social security, income level, 
residence, Charlson Comorbidity Index (CCI),[14, 15] 
hypertension and diabetes mellitus. Age was divided 
to 4 groups (20-34, 35-49, 50-64, 65 and over years). 
The type of social security consists of medical aid and 
health insurance in Korea. Health insurance was 
divided into industrial worker (IW) and self-employer 
(SE). Income level was recoded into 5 categories, from 
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quintile 1 (low) to quintile 5 (high), according to 
insurance premiums of householders. The residence 
was divided into capital city (Seoul), big cities, 
medium and small cities and rural areas. The CCI was 
recoded into 3 categories (0, 1, ≥2). The hypertension 
and diabetes mellitus were defined as cases of subjects 
diagnosed with I10 ~ I15 and E10 ~ E14 in 2003. 
Survival time was the number of months between the 
baseline and the event of CRC. 
Table 1. General characteristics of subjects, according to 
presence of colorectal cancer. Unit: N, (%). 
  
Total 
With  
No 
Cancer 
With  
Cancer p-value 
Total 745,641 738,193 (99.0) 
7,448 
(1.0)  
Gender 
Male 366,251 362,047 (98.8) 
4,204 
(1.2) <.0001 
Female 379,390 376,146 (99.1) 
3,244 
(0.9)  
Age 
20 ~ 34 269,032 268,630 (99.8) 
402 
(0.2) <.0001 
35 ~ 49 257,534 255,684 (99.3) 
1,850 
(0.7)  
50 ~ 64 139,828 136,752 (97.8) 
3,076 
(2.2)  
≥ 65 79,247 77,127 (97.3) 
2,120 
(2.7)  
Type of  
social 
security 
Medical aid 22,038 21,854 (99.2) 
184 
(0.8) 0.0040 
Health 
insurance (IW) 362,785 
359,050 
(99.0) 
3,735 
(1.0)  
Health 
insurance (SE) 360,818 
357,289 
(99.0) 
3,529 
(1.0)  
Income level 
1  quintile(low) 123,699 122,563 (99.1) 
1,136 
(0.9) <.0001 
2  quintile 121,352 120,325 (99.2) 
1,027 
(0.8)  
3  quintile 144,515 143,287 (99.2) 
1,228 
(0.8)  
4  quintile 166,932 165,322 (99.0) 
1,610 
(1.0)  
5  quintile(high) 189,143 186,696 (98.7) 
2,447 
(1.3)  
Residence 
Seoul 163,896 162,051 (98.9) 
1,845 
(1.1) <.0001 
Big cities 194,830 193,071 (99.1) 
1,759 
(0.9)  
Medium, small 
Cities 305,887 
303,063 
(99.1) 
2,824 
(0.9)  
Rural area 81,028 80,008 (98.7) 
1,020 
(1.3)  
Charlson 
Comorbidity 
Index 
0 549,311 544,897 (99.2) 
4,414 
(0.8) <.0001 
1 126,353 124,718 (98.7) 
1,635 
(1.3)  
≥ 2 69,977 68,578 (98.0) 
1,399 
(2.0)  
Hypertension 
Non-Diagnosed 682,923 676,993 (99.1) 
5,930 
(0.9) <.0001 
Diagnosed 62,718 61,200 (97.6) 
1,518 
(2.4)  
Diabetes 
mellitus 
Non-Diagnosed 716,027 709,304 (99.1) 
6,723 
(0.9) <.0001 
Diagnosed 29,614 28,889 (97.5) 
725 
(2.5)  
Ulcerative 
colitis 
Non-Diagnosed 745,119 737,683 (99.0) 
7,436 
(1.0) 0.0028 
Diagnosed 522 510 (97.7) 12 (2.3)  
IW: industrial worker, SE: self-employee 
Statistical Analysis 
We compared independent variables using 
x2-test according to the presence of CRC. The results 
were expressed as frequency (%). After performing 
preliminary analyses, we used Cox proportional 
hazard regression model to estimate the hazard ratio 
(HR) for the incidence of CRC. Covariates included 
baseline age (ref: 20-34 years old), type of social 
security (ref: Health insurance (IW)), income level (ref: 
1 quintile), residence (ref: rural areas), CCI (ref: 0), 
hypertension (ref: non-diagnosed), diabetes mellitus 
(ref: non-diagnosed). Kaplan-Meier survival curve 
method was conducted to determine probability of 
incidence for group with UC relative to the reference 
group (non-diagnosed). Statistical analysis was 
performed using the SAS version 9.2. P-value < 0.05 
was considered to be significant. 
Results 
Baseline characteristics of subjects were shown 
according to incidence of CRC (Table 1). There were 
7,448 new cases of CRC during 11 years (2003~2013), 
4,204 of which occurred in male and 3,244 of which 
occurred in female. The incidence of CRC was higher 
in male than in female. CRC developed in 2.3% of the 
UC group and 1.0% in the non-UC group. Figure 2 
shows the difference in development of CRC 
according to diagnosis of UC. Risk of CRC was over 2 
fold higher in subjects with UC. The incidence of UC 
was 6.7 per 100,000 from 2003 to 2013. The incidence 
of CRC was 95.4 per 100,000 from 2003 to 2013. 12 of 
the patients with UC (n=522) were diagnosed CRC. 
Overall, annual incidence of CRC in male and female 
were 110.2 and 81.2 per 100,000. Average durations at 
CRC diagnosis of patients with UC were 3.39 year. 
 
Figure 2. Difference in development of CRC according to diagnosis of UC 
 
Table 2 showed the risk factors of being 
diagnosed with CRC during the follow-up period. HR 
of UC in CRC incidence of female (0.63 (95% 
confidence interval (CI): 0.60-0.65)) was lower than 
male. HRs of age group steadily increased in CRC 
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incidence (4.73 (95% CI: 4.24-5.27) in 30-49 years old, 
14.40 (95%.CI: 12.96-16.00) in 50-64 years old, 22.39 
(95% CI: 20.04-25.02) in 65 years old and over) than 
reference group (20-34 years old). HR medical aid 
group was 0.66 (95% CI: 0.56-0.78) than health 
insurance IW group. HR of highest income level was 
1.18 (95% CI: 1.10-1.28) than the lowest income group. 
HR of group residing in Seoul was 1.18 (95% CI: 
1.09-1.28) than group residing in rural area. HRs of 
group with CCI=1 and ≥ 2 were 1.12 (95% CI: 
1.05-1.18) and 1.29 (95% CI: 1.20-1.37) than group with 
CCI=0, respectively. HRs of group with hypertension 
and diabetes mellitus were 1.13 (95% CI: 1.06-1.20) 
and 1.15 (95% CI: 1.06-1.25) than group of healthy 
subjects, respectively. HR of patients with UC was 
1.92 (95% CI: 1.09-3.38) than group without UC in 
incidence of CRC.  
Figure 3 showed the results of Kaplan-Meier 
survival curves. The incidence probability of patients 
with UC was higher than the group without UC. The 
incidence probability of male with UC was higher 
than that of female with UC. 
 
Figure 3. Kaplan-Meier curve of subjects by gender over 10 years, according to 
presence of ulcerative colitis 
Table 2. Risk factor influencing the incidence of colorectal cancer 
 HR 95% CI 
Gender (ref: Male) 1.00  
Female 0.63 (0.60-0.65) 
Age (ref: 20 ~ 34) 1.00  
35 ~ 49 4.73 (4.24-5.27) 
50 ~ 64 14.40 (12.96-16.00) 
≥ 65 22.39 (20.04-25.02) 
Type of social security (ref:  Health 
insurance_IW) 
1.00  
Medical aid 0.66 (0.56-0.78) 
Health insurance(SE) 0.96 (0.91-1.00) 
Income level (ref: 1 quintile) 1.00  
2  quintile 1.04 (0.95-1.13) 
3  quintile 1.03 (0.95-1.13) 
4  quintile 1.06 (0.98-1.15) 
5  quintile (high) 1.18 (1.10-1.28) 
Residence (ref: Rural area) 1.00  
Seoul 1.18 (1.09-1.28) 
Big cities 0.96 (0.88-1.03) 
Medium, small Cities 0.95 (0.89-1.03) 
Charlson Comorbidity Index (ref: 0) 1.00  
1 1.12 (1.05-1.18) 
≥ 2 1.29 (1.20-1.37) 
Hypertension (ref: Non-diagnosed) 1.00  
Diagnosed 1.13 (1.06-1.20) 
Diabetes mellitus (ref: Non-diagnosed) 1.00  
Diagnosed 1.15 (1.06-1.25) 
UC (ref: Non-diagnosed) 1.00  
Diagnosed 1.92 (1.09-3.38) 
IW: industrial worker, SE: self-employee 
 
Discussion 
This study was conducted to identify the UC 
effect on the CRC incidence. This study confirms 
previous findings that UC patients have a higher 
frequency of CRC than non-UC patients. 
Furthermore, male UC patients are at higher risk than 
female UC patients. 
According to results, the annual incidence of UC 
and CRC were 6.7 and 95.4 per 100,000 during 11 
years (2003~2013). In previous study using 
registration program for RID in Korea, the annual 
incidence of UC was 4.6 per 100,000 during 7 years 
(2006~2012).[12] The crude incidence rate per 100,000 
of CRC of 2012 was 57.6 (male: 69.3; female 45.9) in 
2012.[1] The reason why incidence of UC and CRC in 
this study might have excluded subjects under 20 
years of age from analysis, is that subjects who were 
less than 20 years of age account for about 25% of the 
entire population.  
CRC most frequently results from mutations in 
the Wnt signaling pathways that increases signaling 
activity. The mutations occur in the intestinal crypt 
stem cell.[16] The risk factors of CRC include male 
gender, increasing age, high intake of fat, alcohol or 
red meat, obesity, income, smoking, a lack of physical 
exercise, and family history of CRC.[17-19] The UC is 
associated with development of CRC.[5-7, 19, 20] The 
difference in result of analyses was explained by 
different methodology, target populations and 
follow-up period. 
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A meta-analysis on the incidence of 
UC-associated CRC found that cumulative incidence 
of CRC was 2% at 10-year, 8% at 20-year and 18% at 
30-year follow-up.[21] In case of Korea, the 
cumulative incidence of UC-associated CRC was 0.7% 
at 10-year, 7.9% at 20-year, and 33.2% at 30-year 
follow-up.[22] According to the results, the 
cumulative incidence of UC-associated CRC was 2.3% 
at 11-year follow-up. 
Some epidemiologic studies have shown a 
higher risk of CRC in male than in female. This 
difference in risk of CRC between genders is not 
easily explained.[19] Increasing age is associated with 
an increased risk of CRC.[18] Socio-demographic 
indicators, such as income and residence might 
partially explain the increased incidence of CRC.[17, 
23] Furthermore, the HR of CRC of the highest income 
level is significantly higher than that of lowest income 
level. Regional differences in screening also might 
affect detection of CRC. Risk factors associated with 
incidence of CRC are diagnoses of hypertension and 
diabetes mellitus.[18, 24] Finding from this study 
revealed that patients with hypertension or diabetes 
mellitus might be more likely to be diagnosed as CRC 
than healthy people without hypertension or diabetes 
mellitus. 
In Korea, the target cancers of NCSP (National 
Cancer Screening Program) include stomach cancer, 
breast cancer, CRC, liver cancer, and cervical cancer. It 
is recommended for individuals aged ≥ 50 years to get 
CRC screening on a yearly basis. CRC screenings are 
performed for screening items stipulated by the 
health screening implementation standards such as 
Fecal Occult Blood Test (FOBT), double-contrast 
examination of the colon, colonoscopy exam, and 
biopsy. Total inspection rate of cancer screening and 
inspection rate of CRC screening were 43.5% and 
30.7% in 2013.[25] The inspection rate of CRC 
screening was lowest among the cancer screenings. 
There are a number of diseases related to UC. 
Some studies found a highly increased risk for 
lymphoma and leukemia in patients with UC.[26, 27] 
The patients with UC have an increased risk of 
developing connective tissue and brain cancer in 
Sweden.[28] There was an increased risk of 
hepatobiliary cancer and non-melanoma skin cancer 
among patients with UC.[19, 29, 30] In addition, an 
Italian population-based study showed an increased 
risk for Hodgkin’s disease among patients with 
UC.[31] 
The source used in analysis was 
population-based representative data containing all 
medical claims and checkup results of population 
from 2002 to 2013. A number of studies have been 
carried out to identify the cause of disease utilizing 
accumulated data via electronic data interchange 
(EDI) in Korea. 
This study had the following limitations. First, 
data based on claims data included only information 
on each episode of health care utilization and 
expenditure. Claim data used in analysis did not 
include clinical findings and disease severity. The 
variables used in this study were limited. Also, 
important co-variates associated with risk of CRC in 
UC are not available for the cohort thus limiting the 
value of the findings. The factors that influenced 
association between UC and CRC were age at initial 
diagnosis, life style, and family history of CRC.[32-34] 
Second, follow-up period was short (11 years), which 
might have precluded the detection of significant 
effects of UC on subsequent incidence of CRC. The 
incidence of CRC begins to increase 8 or 10 years after 
the initial diagnosis of UC.[19, 30, 35] 
In conclusion, the cancer caused financial and 
psychological burden to the caregiver, as well as pain 
of patients. CRC is a disease attributable to 
inappropriate behavior patterns and lifestyle. 
Prevention is the best cure for cancer. To reduce the 
incidence of CRC in patients with UC, it is important 
to identify predictive and protective factors for CRC. 
Developing cancer prevention strategies might be 
helpful in containing the incidence of cancer to 
selected high-risk groups. 
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